Transdermal estradiol treatment during breastfeeding: maternal and infant serum concentrations
- PMID: 25956588
- PMCID: PMC4641053
- DOI: 10.1007/s00737-015-0532-1
Transdermal estradiol treatment during breastfeeding: maternal and infant serum concentrations
Abstract
We examined estradiol (E2) and estrone (E1) concentrations in breastfeeding mother-infant dyads. The mothers had postpartum depression and were participants in a randomized clinical trial with three treatments (transdermal E2, sertraline, and placebo). Neither infant E1 and E2 concentrations nor infant growth differed across the treatments. Transdermal E2 administration of 50 to 200 mcg/day for breastfeeding women did not affect infant E1 or E2 concentrations or infant growth.
Keywords: Breastfeeding; Estradiol; Infant; Major depressive disorder; Postpartum depression.
References
-
- Ahokas A, Kaukoranta J, Wahlbeck K, Aito M. Estrogen deficiency in severe postpartum depression: successful treatment with sublingual physiologic 17beta-estradiol: a preliminary study. Journal of Clinical Psychiatry. 2001;62:332–336. - PubMed
-
- Ball DE, Morrison P. Oestrogen transdermal patches for post partum depression in lactating mothers--a case report. Central African Journal of Medicine. 1999;45:68–70. - PubMed
-
- Centers for Disease Control and Prevention Breastfeeding Report Card: United States. 2014.
-
- Gregoire A, Kumar R, Everitt B, Studd J. Transdermal oestrogen for treatment of severe postnatal depression. The Lancet. 1996;347:930–933. - PubMed
-
- Illingworth PJ, Seaton JE, McKinlay C, Reid-Thomas V, McNeilly AS. Low dose transdermal oestradiol suppresses gonadotrophin secretion in breast-feeding women. Human Reproduction. 1995;10:1671–1677. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
